Study Set Content:
a lymphocyte selective immunosuppressant that is prepared by immunizing horses with human thymus cells and then isolating the equine gamma globulin
Lymphocyte Immune Globulin
derived from human blood plasma containing antibody to the erythrocyte factor Rh0 (D
RH0 (D) Immune Globulin
blood that has been drawn from a selected donor under rigid aseptic conditions, contains citrate ion or heparin as an anticoagulant
Whole blood
whole blood from which plasma has been removed
Red blood cells
prepared from prothrombin of bovine origin through interaction with added thromboplastin in the presence of calcium
Thrombin
Used as a blood replenisher
Whole blood
used as a blood replenisher; anemia
Red blood cells
• local hemostatic • applied topically to control blood oozing from capillaries and small venules when the area is accessible
Thrombin
useful in dental surgery, laryngeal and nasal surgery, plastic surgery, and skin grafting procedures
Thrombin
useful for passive immunization against tetanus in individuals with wounds that may have been contaminated with tetanus microorganism
Tetanus immune globulin
indicated for passive protection against rabies in persons suspected of exposure to rabies Its use is the same as antirabies serum; however, because it is of human origin, it possesses the added advantage of removing the risk of serum sickness
Rabies Immune Globulin
Chicken pox
Varicella-zoster immune globulin
Hepatitis B
Hepatitis B immune globulin
antibody that neutralizes the antigen in Rh-positive blood, which sensitizes Rh-negative women and results in Rh hemolytic disease of the newborn
RHD factor
indicated for use in organ transplant.
Lymphocyte Immune Globulin
stored at a constant temperature of between 1 and 6° C
Whole blood
Note exp date in the book depending on the () used
anticoagulant
storage at —65° C or colder
Red blood cells
Solutions should be used within a few hours after preparation
Thrombin
Antihemophilic factor: sterile, freeze-dried concentrate of human antihemophilic factor (prepared from the factor () fraction of human venous plasma) for use in the therapy of () (classic hemophilia) by accelerating the abnormally slow clotting time.
VIII-rich cryoprotein , hemophilia A
